Vectors

dc.contributor.authorTello López
dc.contributor.authorTriatoma Williami
dc.contributor.authorGabriela de
dc.contributor.authorRosa da
dc.contributor.authorPatrícia Cuervo
dc.contributor.authorElisa Cupolillo
dc.contributor.authorThiago Moreno L. Souza
dc.contributor.authorOliveira
dc.contributor.authorJankevicius
dc.contributor.authorGaziri
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:26:14Z
dc.date.available2026-03-22T16:26:14Z
dc.date.issued2003
dc.descriptionCitaciones: 1
dc.description.abstractChagas disease is the most important parasitic disease in Latin America, as in Mexico, where 1.5-2% of blood donations are contaminated with anti-Trypanosoma cruzi antibody. Through environmental and population based stratification, we estimate that 91 million inhabitants are at risk (78% through residence), 1,768,376 individuals are infected, and mortality may oscillate between 25,500 and 63,000 individuals/yr (830 of these are under 5 yrs old). The disease incidence is estimated at 69,000 cases/yr and approximately 530,500 individuals are currently in chronic phase. More than 96% of the transmission occurs via the vector, and niche modeling with GARP estimates that 67% of the transmission occurs via one of the 6 primary phyllosoma complex species.
dc.identifier.doi10.1590/s0036-46652003000700011
dc.identifier.urihttps://doi.org/10.1590/s0036-46652003000700011
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/58231
dc.language.isopt
dc.publisherUniversity of São Paulo
dc.relation.ispartofRevista do Instituto de Medicina Tropical de São Paulo
dc.sourceUniversidad Nacional Autónoma de México
dc.subjectMedicine
dc.titleVectors
dc.typearticle

Files